Jump to main content
Takeda will discontinue global manufacturing of NATPARA by the end of 2024. Learn How This May Affect You

NATPARA Administration Kit Components

The Mixing Device and Q-Cliq Pen

The Mixing Device and Q-Cliq Pen.

NATPARA Medication Cartridges are designed for use with the following:

  • Reusable Mixing Device for product reconstitution
  • Reusable Q-Cliq pen(s) for drug delivery

The Q-Cliq pen is designed to deliver a fixed dose and can be used for up to 2 years of daily treatment. The NATPARA Medication Cartridge(s) should be discarded on the 15th day, following two weeks (14 days) of treatment.1

NATPARA Q-Cliq Pen needle.

31G x 8mm

BD Ultra-Fine™ Pen Needle

The needle is approximately the width of two human hairs.2,3

Additional supplies

The NATPARA Administration Kit will also include:

  • Disposable needles
  • Alcohol swabs
  • NATPARA Medication Cartridge Tracker

A puncture-resistant container (“sharps” container) is also required, but it is not provided in the NATPARA Administration Kit.

References: 1. NATPARA [package insert]. Shire Pharmaceuticals, Inc. 2. Sigma-Aldrich Co. LLC. Syringe needle gauge chart. Sigma-Aldrich Website. http://www.sigmaaldrich.com/chemistry/stockroom-reagents/learning-center/technical-library/needle-gauge-chart.html. Accessed April 24, 2017. 3. US Department of Energy. The scale of things – nanometers and more. National Nanotechnology Infrastructure Network Website. http://www.nnin.org/sites/default/files/files/scale_of_things_26may06.pdf. Accessed April 24, 2017.

NATPARA® and the NATPARA Logo® are registered trademarks of Takeda Pharmaceuticals, U.S.A,. Inc.